Your browser doesn't support javascript.
loading
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients.
de Souza, Sávio Bastos; Cabral, Paula Gebe Abreu; da Silva, Renato Martins; Arruda, Raul Ferraz; Cabral, Sheila Passos de Figueiredo; de Assis, Arícia Leone Evangelista Monteiro; Viana Junior, Antônio Brazil; Degrave, Wim Maurits Sylvain; Moreira, Aline Dos Santos; Silva, Cléber Glória; Chang, Junbiao; Lei, Pingsheng.
Afiliação
  • de Souza SB; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • Cabral PGA; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • da Silva RM; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • Arruda RF; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • Cabral SPF; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • de Assis ALEM; High Complexity Center, Galzu Institute, Campos dos Goytacazes, Brazil.
  • Viana Junior AB; UFC/Ebserh University Hospital Complex, Fortaleza, Brazil.
  • Degrave WMS; Functional Genomics and Bioinformatics Laboratory, Oswaldo Cruz Institute - FIOCRUZ, Rio de Janeiro, Brazil.
  • Moreira ADS; Functional Genomics and Bioinformatics Laboratory, Oswaldo Cruz Institute - FIOCRUZ, Rio de Janeiro, Brazil.
  • Silva CG; Santa Casa de Misericórdia de Campos Hospital, Campos dos Goytacazes, Brazil.
  • Chang J; NMPA Key Laboratory for Research and Evaluation of Innovative Drug, Henan Normal University, Xinxiang, China.
  • Lei P; Institute of Material Medical, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Med (Lausanne) ; 10: 1215916, 2023.
Article em En | MEDLINE | ID: mdl-37928473

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article